Fullerton D S, Yoshioka K, Rohrer D C, From A H, Ahmed K
J Med Chem. 1979 May;22(5):529-33. doi: 10.1021/jm00191a014.
(20R)-20,22-Dihydrodigitoxigenin (3a) and (20S)-20,22-dihydrodigitoxigenin (3b) were isolated from (20R,S)-20,22-dihydrodigitoxigenin (3) by three fractional crystallizations each from ethyl acetate. The two diastereomers have distinct NMR spectra and similar (Na+,K+)ATPase inhibitory activities (I50 = 1.1-1.4 X 10(-5) M)--about 1/100 as active as digitoxigenin (1). Their activity compared with other cardenolide analogues suggests a passive geometric role for the 20(22) double bond in eliciting (Na+,K+)ATPase inhibition, keeping the lactone carbonyl in the proper orientation. (20S)-3 beta,14 beta-Dihydroxy-22-methylene-5 beta,14 beta-cardanolide (7a) was then synthesized from 3a, and (20R)-3 beta,14 beta-dihydroxy-22-methylene-5 beta,14 beta-cardanolide (7b) from 3b. They were found to be equivalently active in inhibiting (Na+,K+)ATPase, with I50 values of 7.0 x 10(-5) M. Although it has been usually believed that the 14 beta-hydroxyl of cardenolides increases binding to the receptor, 2b (the 14-ene derivative of 7b) was more than twice as active (I50 = 3.0 X 10(-5)) than either 7a or 7b.
(20R)-20,22-二氢洋地黄毒苷元(3a)和(20S)-20,22-二氢洋地黄毒苷元(3b)通过从乙酸乙酯中各进行三次分步结晶,从(20R,S)-20,22-二氢洋地黄毒苷元(3)中分离得到。这两种非对映异构体具有不同的核磁共振谱,且具有相似的(Na+,K+)ATP酶抑制活性(I50 = 1.1 - 1.4×10(-5) M)——活性约为洋地黄毒苷元(1)的1/100。它们与其他强心苷类似物的活性比较表明,20(22)双键在引发(Na+,K+)ATP酶抑制中起被动几何作用,使内酯羰基保持在适当的方向。然后由3a合成了(20S)-3β,14β-二羟基-22-亚甲基-5β,14β-强心甾内酯(7a),由3b合成了(20R)-3β,14β-二羟基-22-亚甲基-5β,14β-强心甾内酯(7b)。发现它们在抑制(Na+,K+)ATP酶方面具有同等活性,I50值为7.0×10(-5) M。尽管通常认为强心苷的14β-羟基会增加与受体的结合,但2b(7b的14-烯衍生物)的活性比7a或7b高出两倍多(I50 = 3.0×10(-5))。